Kirsten Flowers
Net Worth
Last updated:
What is Kirsten Flowers net worth?
The estimated net worth of Ms. Kirsten Flowers is at least $1,500,009 as of 27 Jan 2023. She owns shares worth $151,035 as insider, has earned $26,474 from insider trading and has received compensation worth at least $1,322,500 in Kura Oncology, Inc..
What is the salary of Kirsten Flowers?
Ms. Kirsten Flowers salary is $661,250 per year as Chief Commercial Officer in Kura Oncology, Inc..
How old is Kirsten Flowers?
Ms. Kirsten Flowers is 50 years old, born in 1975.
What stocks does Kirsten Flowers currently own?
As insider, Ms. Kirsten Flowers owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | Chief Commercial Officer | 20,605 | $7.33 | $151,035 |
What does Kura Oncology, Inc. do?
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Kirsten Flowers insider trading
Kura Oncology, Inc.
Ms. Kirsten Flowers has made only one insider trade in 2023, according to the Form 4 filled with the SEC. She sold 1,906 units of KURA stock worth $26,474 on 27 Jan 2023.
As of 27 Jan 2023 she still owns at least 20,605 units of KURA stock.
Kura Oncology key executives
Kura Oncology, Inc. executives and other stock owners filed with the SEC:
- Dr. Marc Grasso (52) Chief Financial Officer & Chief Bus. Officer
- Dr. Stephen Dale M.D. (53) Chief Medical Officer
- Dr. Troy Edward Wilson (56) Chairman, Chief Executive Officer & Pres
- Ms. Kathleen Ford (78) Chief Operating Officer
- Ms. Kirsten Flowers (50) Chief Commercial Officer